Latest News
ProtoKinetix AAGP Exhibits Efficacy and Safety in Model of Dry Eye Disease
8 April 2020 - - US-based clinical-stage biomedical company ProtoKinetix, Inc. (OTCQB: PKTX) having recently announced filing for patent protection for new applications of its AAGP (PKX-001) molecule, has released preliminary results in efficacy and ...
LFB Receives FDA Approval of Sevenfact, a New Recombinant Coagulation Factor VIIa, for the Treatment of Adults and Adolescents with Hemophilia A or B with Inhibitors
8 April 2020 - - The US Food and Drug Administration has approved the Biologics License Application 2061 for Sevenfact, a new recombinant coagulation Factor VIIa [coagulation factor VIIa (recombinant)-jncw], for the treatment and control of bleeding ...
Copper Compression Donates 18,000 Reusable Copper-Infused Masks to New York/New Jersey Metro-Area Health Systems to Aid in Fight Against COVID-19
8 April 2020 - - US-based Copper Compression, a designer, manufacturer and provider of a range of copper-infused recovery wearables and self-care solutions, has donated and delivered 18,000 Kn99 copper-infused face masks across several local New York...
Agenus awarded FDA's fast track designation for balstilimab for treating cervical cancer
8 April 2020 - Immuno-oncology company Agenus Inc (NASDAQ:AGEN) reported on Tuesday the receipt of US Food and Drug Administration (FDA) Fast Track designation for investigation of balstilimab (anti-PD-1) for the treatment of cervical cancer.The FDA ...
Zelira Therapeutics concludes world's first clinical trial in insomnia patients with medical cannabis ZTL-101
8 April 2020 - Cannabis medicines company Zelira Therapeutics Ltd (ASX:ZLD) (OTCQB:ZLDAF) said on Tuesday that its ZTL-101 medicinal cannabis trial for insomnia demonstrated the treatment as safe and effective for chronic insomnia based on the first ...